Current emerging and investigational drugs for the treatment of chronic hand eczema
- 17 June 2022
- journal article
- research article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 31 (8) , 843-853
Abstract
: Chronic hand eczema (CHE) is a highly prevalent, burdensome condition associated with functional impairment. Currently, topical therapeutics are the mainstay of CHE management. However, many case...Keywords
This publication has 100 references indexed in Scilit:
- Prevalence, incidence and predictive factors for hand eczema in young adults – a follow-up studyBMC Dermatology, 2013
- Jakinibs: a new class of kinase inhibitors in cancer and autoimmune diseaseCurrent Opinion in Pharmacology, 2012
- Efficacy and Tolerability of Alitretinoin for Chronic Hand Eczema Under Daily Practice Conditions: Results of the TOCCATA Open Study Comprising 680 PatientsActa Dermato-Venereologica, 2012
- Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalitiesJournal of Allergy and Clinical Immunology, 2011
- Tight junction defects in patients with atopic dermatitisJournal of Allergy and Clinical Immunology, 2011
- Selectivity and therapeutic inhibition of kinases: to be or not to be?Nature Immunology, 2009
- Janus kinases in immune cell signalingImmunological Reviews, 2009
- Hand eczema: causes, course, and prognosis IIContact Dermatitis, 2008
- Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trialBritish Journal of Dermatology, 2008
- Atopic Profiles, Familial Histories, and Coexisting Conditions Associated With Hand EczemaSKINmed: Dermatology for the Clinician, 2005